Barcelona, Spain — December 18, 2025 — Meta Cell Technology (MCT), a company with an international presence that specializes in enhancing regenerative medical treatments through cutting-edge technology, announces its continued development in the Asian market. Through a combination of high-level clinical education, congress presence, and a groundbreaking new “MCT Lab” clinic-in-clinic concept, MCT is redefining how regenerative protocols are delivered and perceived by both clinicians and patients.
MCT Lab: Elevating the Patient Experience
As part of its commitment to excellence, MCT is introducing a specialized marketing and operational initiative: the MCT Lab. This concept involves the creation of dedicated MCT treatment centers within prestigious dermatology clinics, starting in South Korea.
The “MCT Lab” is designed to set a premium standard for regenerative treatments. By establishing a private, high-end environment specifically for the MCT System, clinics can offer patients an exclusive experience that distinguishes MCT from standard procedures.
“The goal is to provide a specialized space that reflects the sophisticated nature of our technology,” says the MCT Asian team. “By integrating a dedicated MCT Lab, clinics can emphasize regenerative medicine as their core focus, creating a high-end atmosphere that resonates with patients seeking the highest quality of care.”
Strategic Partnerships Driving Growth
MCT’s successful footprint in Asia is the result of strong collaborations with industry-leading partners. These partnerships are vital in bringing advanced regenerative solutions to an increasing number of clinicians, ensuring that the benefits of MCT’s technology reach patients across the region.
Following the successful pilot of the MCT Lab concept in Korea, Meta Cell Technology plans to gradually implement this premium model across its global network in the future to drive innovation, foster specialized knowledge, and elevate clinical excellence for regenerative medicine professionals.
